Clinical Trial Update: A Research Study for Patients With Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by Allergan for overactive bladder and urinary incontinence has completed enrollment, with results posted on 2010-02-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Allergan Investigational Product

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder, Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2010-02-11